Archives of Clinical Infectious Diseases

Published by: Kowsar

The Association Between Helicobacter pylori Infection and Rosacea

Parviz Saleh 1 , 2 , Mohammad Naghavi-Behzad 3 , Sara Babapour 3 and Reza Piri 4 , *
Authors Information
1 Research Center for Infectious Diseases & Tropical Medicine, Infectious and Tropical Diseases Department, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Chronic Kidney Diseases Research Center, Infectious and Tropical Diseases Department, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Student’s Research Committee, Tabriz University of Medical Sciences, Tabriz, IR Iran
4 Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: January 2018, 13 (1); e57740
  • Published Online: January 28, 2018
  • Article Type: Research Article
  • Received: December 4, 2016
  • Revised: July 7, 2017
  • Accepted: September 22, 2017
  • DOI: 10.5812/archcid.57740

To Cite: Saleh P, Naghavi-Behzad M, Babapour S, Piri R. The Association Between Helicobacter pylori Infection and Rosacea, Arch Clin Infect Dis. 2018 ; 13(1):e57740. doi: 10.5812/archcid.57740.

Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Mobley HLT, Mendz GL, Hazell SL.National Library of Medicine. Helicobacter pylori physiology and genetics. Washington, DC: ASM Press; 2001.
  • 2. Sutton P, Mitchell H. Helicobacter pylori in the 21st Century. 17. CABI; 2010.
  • 3. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56(6):772-81. doi: 10.1136/gut.2006.101634. [PubMed: 17170018].
  • 4. Gasbarrini A, Franceschi F, Gasbarrini G, Pola P. Extraintestinal pathology associated with Helicobacter infection. Eur J Gastroenterol Hepatol. 1997;9(3):231-3. [PubMed: 9096420].
  • 5. Tan HJ, Goh KL. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J Dig Dis. 2012;13(7):342-9. doi: 10.1111/j.1751-2980.2012.00599.x. [PubMed: 22713083].
  • 6. Dufour C, Brisigotti M, Fabretti G, Luxardo P, Mori PG, Barabino A. Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr. 1993;17(2):225-7. [PubMed: 8229554].
  • 7. Taghavi Zenouz A, Mehdipour M, Heydarlou M, Gholizadeh N. Relationship between lichen planus and Helicobacter pylori infection. J Dent Res Dent Clin Dent Prospects. 2010;4(1):17.
  • 8. Ghotaslou R, Milani M, Akhi MT, Nahaei MR, Hasani A, Hejazi MS, et al. Diversity of Helicobacter Pylori cagA and vacA Genes and Its Relationship with Clinical Outcomes in Azerbaijan, Iran. Adv Pharm Bull. 2013;3(1):57-62. doi: 10.5681/apb.2013.010. [PubMed: 24312813].
  • 9. Estakhri R, Somi MH, Rohbakhsh K, Vahedi A, Poorasghary B. The Effects of Helicobacter Pylori Eradication in Blood Level of Biochemical Parameters Related to Coronary Heart Diseases. Med J Tabriz Univ Med Sci Health Serv. 2013;35(5):6-11.
  • 10. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291(2):187-94. doi: 10.1001/jama.291.2.187. [PubMed: 14722144].
  • 11. Salehi MR, Aboei MS, Naghsh N, Hajisadeghi S, Ajami E. A comparison in prevalence of Helicobacter pylori in the gingival crevicular fluid from subjects with periodontitis and healthy individuals using polymerase chain reaction. J Dent Res Dent Clin Dent Prospects. 2013;7(4):238.
  • 12. Kramer AD, Guillory JE, Hancock JT. Experimental evidence of massive-scale emotional contagion through social networks. Proc Natl Acad Sci U S A. 2014;111(24):8788-90. doi: 10.1073/pnas.1320040111. [PubMed: 24889601].
  • 13. Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002;359(9310):931-5. doi: 10.1016/S0140-6736(02)08025-X. [PubMed: 11918912].
  • 14. Malaty HM, Logan ND, Graham DY, Ramchatesingh JE. Helicobacter pylori infection in preschool and school-aged minority children: effect of socioeconomic indicators and breast-feeding practices. Clin Infect Dis. 2001;32(10):1387-92. doi: 10.1086/320148. [PubMed: 11317237].
  • 15. Irani S, Esfahani AM, Zerehpoush F. Detection of Helicobacter pylori in oral lesions. J Dent Res Dent Clin Dent Prospects. 2013;7(4):230.
  • 16. Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol. 2002;3(4):273-82. [PubMed: 12010072].
  • 17. Shiotani A, Okada K, Yanaoka K, Itoh H, Nishioka S, Sakurane M, et al. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter. 2001;6(1):60-5. [PubMed: 11328367].
  • 18. Zandi S, Shamsadini S, Zahedi MJ, Hyatbaksh M. Helicobacter pylori and rosacea. East Mediterr Health J. 2003;9(1-2):167-71. [PubMed: 15562747].
  • 19. Hernando-Harder AC, Booken N, Goerdt S, Singer MV, Harder H. Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol. 2009;19(5):431-44. doi: 10.1684/ejd.2009.0739. [PubMed: 19527988].
  • 20. El-Khalawany M, Mahmoud A, Mosbeh AS, A. B. D. Alsalam F , Ghonaim N, Abou-Bakr A. Role of Helicobacter pylori in common rosacea subtypes: a genotypic comparative study of Egyptian patients. J Dermatol. 2012;39(12):989-95. doi: 10.1111/j.1346-8138.2012.01675.x. [PubMed: 23039081].
  • 21. Bhattarai S, Agrawal A, Rijal A, Majhi S, Pradhan B, Dhakal SS. The study of prevalence of Helicobacter pylori in patients with acne rosacea. Kathmandu Univ Med J (KUMJ). 2012;10(40):49-52. [PubMed: 23575053].
  • 22. Prelipcean CC, Mihai C, Gogălniceanu P, Mitrică D, Drug VL, Stanciu C. Extragastric manifestations of Helicobacter pylori infection. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi. 2007;111(3):575-83.
  • 23. Yousefi L, Ghotaslou R, Akhi MT, Asgharzadeh M, Nahaei MR, Rafeey M. Frequency of Helicobacter pylori blood-group antigen-binding adhesion 2 and sialic acid binding adhesion genes among dyspeptic patients in Tabriz, Iran. J Analyt Res Clin Med. 2015;3(2):71-6. doi: 10.15171/jarcm.2015.011.
  • 24. Dakovic Z, Vesic S, Vukovic J, Milenkovic S, Jankovic-Terzic K, Dukic S, et al. Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: a case series. Acta dermatovenerologica Alpina, Pannonica, et Adriatica. 2007;16(2):83-6.
  • 25. Mayr-Kanhauser S, Kranke B, Kaddu S, Mullegger RR. Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. Eur J Gastroenterol Hepatol. 2001;13(11):1379-83. [PubMed: 11692067].
  • 26. Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med. 1997;90(3):144-50. [PubMed: 9135612].
  • 27. Odom R, Dahl M, Dover J, Draelos Z, Drake L, Macsai M, et al. Standard management options for rosacea, part 2: options according to subtype. Cutis. 2009;84(2):97-104. [PubMed: 19746768].
  • 28. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol. 2002;16(4):328-33. [PubMed: 12224687].
  • 29. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;19 Suppl 1:1-5. doi: 10.1111/hel.12165. [PubMed: 25167938].
  • 30. Milani M, Ghotaslou R, Akhi MT, Nahaei MR, Hasani A, Somi MH, et al. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. J Infect Chemother. 2012;18(6):848-52. doi: 10.1007/s10156-012-0425-4. [PubMed: 22581031].
  • 31. Mansour-Ghanaei F, Mashhour M, Joukar F, Sedigh M, Bagher-Zadeh AH, Jafarshad R. Prevalence of Helicobacter pylori infection among children in Rasht, Northern Iran. Middle East J Digest Dis. 2009;1(2):84-8.
  • 32. Saleh P, Naghavi-Behzad M, Herizchi H, Mokhtari F, Mirza-Aghazadeh-Attari M, Piri R. Effects of Helicobacter pylori treatment on rosacea: A single-arm clinical trial study. J Dermatol. 2017;44(9):1033-7. doi: 10.1111/1346-8138.13878. [PubMed: 28452093].
  • 33. Argenziano G, Donnarumma G, Iovene MR, Arnese P, Baldassarre MA, Baroni A. Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol. 2003;42(8):601-4. [PubMed: 12890101].
  • 34. Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24(5):565-71. doi: 10.1111/j.1468-3083.2009.03472.x. [PubMed: 19874433].
  • 35. Utas S, Ozbakir O, Turasan A, Utas C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol. 1999;40(3):433-5. [PubMed: 10071314].
  • 36. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327-41. quiz 342-4. doi: 10.1016/j.jaad.2004.03.030. [PubMed: 15337973].
  • 37. Alborzi A, Soltani J, Pourabbas B, Oboodi B, Haghighat M, Hayati M, et al. Prevalence of Helicobacter pylori infection in children (south of Iran). Diagn Microbiol Infect Dis. 2006;54(4):259-61. doi: 10.1016/j.diagmicrobio.2005.10.012. [PubMed: 16466888].
  • 38. Saleh P, Zarrintan A, Zeinal Zade AH, Piri R, Mohammadi S, Naghavi-Behzad M. Efficiency of Helicobacter pylori Infection Treatment Protocol: Clarithromycin, Amoxicillin and Omeprazole. Arch Clin Infect Dis. 2012;8(1):14-7. doi: 10.5812/archcid.14408.
  • 39. Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Farkkila M, Haapiainen R, et al. Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol. 2000;35(2):138-41. [PubMed: 10720110].
  • 40. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis. 2010;19(4):409-14. [PubMed: 21188333].
  • 41. Porras C, Nodora J, Sexton R, Ferreccio C, Jimenez S, Dominguez RL, et al. Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701). Cancer Causes Control. 2013;24(2):209-15. doi: 10.1007/s10552-012-0117-5. [PubMed: 23263777].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments